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Abstract
Background: Manganese (Mn) is an essential element for humans, but exposure to high levels has been associated
with adverse developmental outcomes. Early epidemiological studies evaluating the effect of Mn on fetal growth
are inconsistent.
Methods: We investigated the association between maternal urinary Mn during pregnancy and the risk of low
birth weight (LBW). Mn concentrations in maternal urine samples collected before delivery were measured in 816
subjects (204 LBW cases and 612 matched controls) recruited between 2012 and 2014 in Hubei Province, China.
Results: The median Mn concentration in maternal urine was 0.69 μg/g creatinine. Compared to the medium
tertile of Mn levels, an increased risk of LBW was observed for the lowest tertile (≤0.30 μg/g creatinine) [adjusted
odds ratio (OR) = 1.28; 95 % confidence interval (CI) = 0.67, 2.45], and a significantly increased risk of LBW was
observed for the highest tertile (≥1.16 μg/g creatinine) [adjusted OR = 2.04; 95 % CI = 1.12, 3.72]. A curvilinear
relationship between maternal urinary Mn and risk of LBW was observed, showing that the concentration at
0.43 μg/g creatinine was the point of inflection. Similar associations were observed among the mothers with
female infants and among the younger mothers < 28 years old. However, among the mothers with male infants or
the older mothers ≥ 28 years old, only higher levels of Mn were positively associated with LBW.
Conclusions: Lower or higher levels of maternal urinary Mn are associated with LBW, though only the association
of LBW risk and higher levels of Mn was statistically significant. The findings also show that the associations may
vary by maternal age and infant sex, but require confirmation in other populations.
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Background
Low birth weight (LBW), a birth weight less than
2,500 g, constitutes a significant public health problem
in both developing and developed countries. The esti-
mated 30 million LBW infants born annually (23.8 % of
all births) worldwide often face severe short- and long-
term health consequences [1]. LBW is not only a major
determinant of mortality, morbidity and disability in
infancy and childhood [2], but is also associated with a
number of health problems in later life, such as neuro-
developmental disabilities, growth and metabolic disor-
ders, and respiratory disorders [3]. There are growing
concerns about the role of environmental exposures in
the etiology of LBW.
Manganese (Mn) poses a particular challenge in that it
is an essential nutrient for normal development, with
involvement in bone formation, protein and energy me-
tabolism, and metabolic regulation, but it is also a poten-
tial toxicant if overexposure occurs [4]. Mn occurs
naturally in the environment and has several industrial
uses including production of steels, portable batteries,
and aluminum beverage cans. The general population is
exposed to Mn through consumption of food and water,
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inhalation of air, and contact with consumer products
that contain Mn. Human activities such as mining, metal
smelting, and other industrial uses of Mn may increase
Mn levels in the environment [5]. An increasing number
of studies suggest that excess exposure to Mn may have
detrimental effects on the developing organism, particu-
larly neurological development [6, 7]. Also, maternal ex-
posure to high levels of Mn through drinking water in
Bangladesh has been related to increased fetal abnormal-
ities and fetal mortality [8].
Unlike other toxic metals like lead, which have no
beneficial use in the human body, the effects of Mn on
fetal growth are likely to be more complex because it is
both an essential nutrient and a potential toxicant, de-
pending on the amount of exposure. Findings from stud-
ies evaluating prenatal exposure to Mn and birth size
have been inconsistent. Maternal exposure to elevated
levels of Mn in water has been associated with a reduc-
tion in birth weight [9]. However, some studies evaluat-
ing birth weight and maternal blood Mn levels have
observed no such association [10, 11], and a previous
study indicated that lower maternal blood Mn levels
were associated with intrauterine growth retardation
[12]. A recent study evaluated the association in 470
mother-infant pairs and found that both lower and
higher maternal blood Mn concentrations were associ-
ated with decreased birth weight [13]. Some other stud-
ies subsequently reported similar results and suggested
that there may be a parabolic dose–response relationship
between maternal blood Mn concentrations and birth
weight [14–16].
These studies on Mn exposure and infant birth weight
were limited to only include normal birth weight infants
or included only a few LBW infants in their study popu-
lations and therefore couldn’t estimate the risk for LBW.
With the high rate of industrial development and urban
expansion in China, elevated levels of Mn in air and soil
have been reported in some areas [17, 18], which neces-
sitates further study of the potential effects of this elem-
ent on the developing fetus. Given this background, we
conducted a nested case–control study that included
204 LBW cases and 612 matched controls in Hubei
Province, China. Assessment of Mn exposure levels in
pregnant women can be as a surrogate of exposure to
the unborn child, because Mn can cross the placenta
and transfer from the mother to the fetus [19]. Noninva-
sive urine based analysis is a traditional approach for
evaluating trace-elements levels in the human body.
Several studies conducted worldwide used Mn in urine
to indicate occupational or environmental exposure for
assessing health risks [20–22], and found associations
between urinary Mn levels and adverse health outcomes
[20, 23, 24]. In the present study, we examined the asso-
ciation between maternal urinary Mn concentrations
and the risk of LBW. Potential effect modification by
maternal age and infant sex, which has not been previ-
ously evaluated, was also examined.
Methods
Study population
The subjects in this study were participants in the pro-
spective Healthy Baby Cohort (HBC) study. This study
was conducted at three major maternity hospitals in
Wuhan, Ezhou, and Macheng cities, which are located
in Hubei province, in the central of People’s Republic of
China. Between November 2012 and April 2014, 16,293
women who gave birth at any of the three hospitals were
recruited, and the participation rate was 78.7 %. Partici-
pant mothers received a detailed explanation of the
study procedures and provided written informed consent
at enrollment. The research protocol was approved by
the ethical committee of Tongji Medical College, Huaz-
hong University of Science and Technology, and the
three study hospitals.
In this study, cases were mothers who delivered a
singleton live infant with a birth weight < 2,500 g. Con-
trols were mothers who delivered a singleton live infant
with normal birth weight between ≥ 2,500 g and <
4,000 g. Potential cases and controls were excluded if
they gave birth to multiple infants, a stillborn infant, or
an infant with a birth defect. Women who did not have
urine samples available for analysis were also excluded.
For each case selected, three consecutive individual
controls were randomly selected and matched to one
case by delivery hospital, infant sex, and maternal age at
conception (within 1-year interval). If more suitable
matched controls were available for one case, only the
top three with the closest maternal age to the case were
selected. A total of 204 cases and 612 matched controls
were included in the analysis.
Data collection
Women were interviewed after delivery by specially
trained nurses in the three hospitals. The questionnaire
collected information regarding demographic factors,
household income, education, smoking behavior, and
alcohol consumption. Information on birth outcomes,
reproductive history, disease, and pregnancy complica-
tions were abstracted from the medical records. The
pre-pregnancy body mass index (BMI) of mothers
was calculated using the self-reported weight before
pregnancy and height, which was measured using a
stadiometer. Gestational age was calculated by sub-
tracting the date for the last menstrual period from
the date of delivery. Infant birth weight was measured
by delivery room staff using standardized anthropo-
metric procedures.
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Urinary Mn measurements
The maternal urine samples were obtained during the
hospital admission for delivery, and were collected in
polypropylene tubes and stored at −20 °C prior to ana-
lysis. All samples were coded and analyzed by lab
personnel blind to their origin. Urine samples were
thawed at room temperature before analysis, and 1 mL
of urine from the supernatant was introduced in a
Kirgen polypropylene conical centrifuge tubes. Then,
3 % HNO3 was added to the final volume of 5 mL
for overnight nitrification. The resulting sample was
digested by ultrasound at 40 °C for 1 h and then ana-
lyzed using inductively coupled plasma mass spectrom-
etry (Agilent 7700, Agilent Technologies, Santa Clara,
CA, USA). The standard Reference Material Human
Urine (SRM2670a, National Institute of Standards and
Technology, Gaithersburg, MD, USA) was used as an
external quality control, and sample spike-recoveries
were used to confirm analytical recovery, which was
95 %. A 3 % HNO3 blank was processed in each batch of
samples to control for possible contamination. The sam-
ples were analyzed with an external calibration method,
using eight standard concentrations ranging from 0 to
500 μg/L. The limit of detection (LOD) for Mn in urine
was 0.05 μg/L. Field blanks were also included for qual-
ity control and the levels of Mn in the field blanks were
< LOD. The urine samples below the LOD were given a
value one-half the LOD. Lead, arsenic, cadmium, and
thallium were also measured simultaneously because
previous studies have suggested that these metals are po-
tentially associated with decreasing birth weight [25–28].
Urinary creatinine concentrations were measured using
a commercially available diagnostic enzyme method
(Mindray BS-200 CREA Kit, Shenzhen Mindray Bio-
medical Electronics CO., LTD., Shenzhen, China). Urine
creatinine was used to adjust the urinary Mn concentra-
tions (μg/L) in order to correct for urine dilution, and Mn
concentrations were expressed as μg/g creatinine.
Statistical analysis
The Wilcoxon signed rank test was used to compare
distributions of Mn levels between cases and controls,
because the distribution of maternal urinary Mn was
skewed to the right. Conditional logistic regression ana-
lyses were performed to assess the association between
maternal urinary Mn concentrations and risk of LBW.
Maternal urinary Mn levels were analyzed as categorical
variables based on the tertile distribution of Mn concen-
trations in the controls. Crude and adjusted odds ratios
(ORs) and their 95 % confidence intervals (CIs) were
estimated comparing the lowest and highest tertile of
Mn levels to the medium tertile. Household income was
used to represent socioeconomic status in this study,
because adjustment for income had a larger impact on
the estimate than education. Inclusion of the two vari-
ables together in the adjusted model did not produce
significantly different results compared to the addition
of each individual variable into the model separately. In
the final model, we adjusted for gestational age
(<37 weeks, ≥ 37 weeks), household income (≥50,000, <
50,000 yuan per year), gestational hypertension (No,
Yes), pre-pregnancy body mass index (<18.5, 18.5–23.9,
≥ 24), parity (primiparous, multiparous), and passive
smoking (No, Yes). Additional adjustment for occupa-
tional status, diabetes, and multivitamin supplement use
during pregnancy did not result in material changes in
the observed associations and thus were not included in
the final models. Several metals that have been previ-
ously suggested to be associated with birth weight (lead,
arsenic, cadmium, and thallium) were also adjusted for
in the models to control for potential confounding, but
inclusion of these metal variables either individually or
together did not cause a significant change in the risk
estimates associated with maternal urinary Mn concen-
trations. Smoking and alcohol consumption during preg-
nancy were not included because very few Chinese
women smoke and drink throughout life. Risk estimates
were stratified by infant sex and maternal age, and het-
erogeneity of effects by infant sex and maternal age were
assessed by the Breslow–Day test. In addition, we ap-
plied the SAS macro LGTPHCURV8 [29] to fit re-
stricted cubic splines to conditional logistic model to
examine the possible non-linear relationship between
maternal urinary Mn concentrations and risk of LBW.
Maternal urinary Mn was regarded as a continuous
variable, and the referent value was set to the median.
The output showed the significance level from the
likelihood ratio tests for non-linearity or linearity, and
the results of spline or linear model were plotted. A
two-sided P value of < 0.05 was considered statistically
significant. All data analyses were performed using SAS
(version 9.3; SAS Institute Inc., Cary, NC, USA).
Results
General characteristics of the cases and controls are
presented in Table 1. Of the newborn infants, 49.5 %
were male. The mean maternal age at delivery was
28.1 ± 4.7 years with a range of 17 to 42 years. Com-
pared to the controls, the case mothers were more
likely to have fewer years of education, have a lower
pre-pregnancy body mass index, and report a lower
household income. There were higher proportions of
case mothers who had gestational hypertension. Only
one mother reported smoking and only three mothers
reported drinking alcohol during their pregnancy.
The median Mn concentration in maternal urine was
0.69 μg/g creatinine (Additional file 1: Table S1). The
LBW case mothers had significantly higher urinary Mn
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levels compared to the control mothers (median: 1.09 vs.
0.64 μg/g creatinine, P < 0.01). Older mothers ≥ 28 years
old had elevated Mn concentrations compared to youn-
ger mothers < 28 years old among the controls (median:
0.67 vs. 0.59 μg/g creatinine) and the cases (median: 1.14
vs. 1.01 μg/g creatinine), although these differences were
not statistically significant (P > 0.05). Further, Mn con-
centrations were somewhat higher in the mothers that
gave birth to male infants compared to female infants
among the controls (median: 0.68 vs. 0.59 μg/g creatin-
ine, P > 0.05) and the cases (median: 1.19 vs. 0.93 μg/g
creatinine, P > 0.05).
Table 2 shows the association between maternal urin-
ary Mn levels and LBW risk. Compared to the medium
tertile of Mn concentration (0.30-1.16 μg/g creatinine),
both the lowest and highest tertiles of Mn were associ-
ated with increased risk of LBW in the adjusted analysis,
although the association was only significant for the
highest tertile [adjusted OR = 1.28 (95 % CI: 0.67, 2.45)
for the lowest tertile; adjusted OR = 2.04 (95 % CI: 1.12,
3.72) for the highest tertile]. In the restricted spline
model after adjusting for the potential confounders, we
observed a U-shaped relationship with a concentration
at 0.43 μg/g creatinine as the point of inflection between
maternal urinary Mn and risk of LBW (Fig. 1). However,
the non-linear relationship was not significant (P = 0.12).
Results for stratified analyses by maternal age (<28
and ≥ 28 years) and infant sex are shown in Table 3 and
Table 4, respectively. Among younger mothers (<28 years),
both lower and higher Mn concentrations in urine were
associated with increased risk of delivering LBW infants,
and the association was significant for the highest tertile
[adjusted OR = 1.88 (95 % CI = 0.74, 4.80) for the lowest
Table 1 Basic characteristics of low birth weight cases and
controls [n (%)]
Characteristics Cases (n = 204) Controls (n = 612)
Infant sex
Male 101 (49.5) 303 (49.5)
Female 103 (50.5) 309 (50.5)
Maternal age
< 25 years 48 (23.5) 146 (23.8)
25–29 years 81 (39.7) 242 (39.5)
≥ 30 years 75 (36.7) 224 (36.6)
Education
≤ 9 years 89 (43.6) 167 (27.3)
9–12 years 38 (18.6) 120 (19.6)
> 12 years 77 (37.8) 322 (52.6)
Missing 0 (0.0) 3 (0.5)
Household income
< 50,000 yuan per year 116 (56.9) 275 (44.9)
≥ 50,000 yuan per year 61 (29.9) 279 (45.6)
Missing 27 (13.2) 58 (9.5)
Parity
Primiparous 159 (77.9) 501 (81.9)
Multiparous 45 (22.1) 111 (18.1)
Gestational hypertension
Yes 20 (9.8) 12 (2.0)
No 183 (89.7) 598 (97.7)
Missing 1 (0.5) 2 (0.3)
Gestational diabetes
Yes 7 (3.4) 27 (4.4)
No 197 (96.6) 585 (95.6)
Pre-pregnancy BMI
< 18.5 kg/m2 60 (29.4) 125 (20.4)
18.5–23.9 kg/m2 108 (52.9) 385 (62.9)
≥ 24 kg/m2 26 (12.8) 85 (13.9)
Missing 10 (4.9) 17 (2.8)
Multivitamin supplement during pregnancy
Yes 137 (67.2) 409 (66.8)
No 59 (28.9) 190 (31.1)
Missing 8 (3.9) 13 (2.1)
Smoking during pregnancy
No 198 (97.1) 608 (99.4)
Yes 1 (0.5) 0 (0.0)
Missing 5 (2.4) 4 (0.6)
Passive smoking during pregnancy
Yes 47 (23.0) 129 (21.1)
No 149 (73.0) 464 (75.8)
Missing 8 (3.9) 19 (3.1)
Table 1 Basic characteristics of low birth weight cases and
controls [n (%)] (Continued)
Alcohol use during pregnancy
Yes 2 (1.0) 1 (3.3)
No 196 (96.1) 594 (97.1)
Missing 6 (2.9) 17 (2.8)
Table 2 Risk of low birth weight associated with levels of
manganese in maternal urine
Manganese
(μg/g creatinine)
Cases Controls ORa (95 % CI) ORb (95 % CI)
Total (n = 816)
< 0.30 55 204 1.11 (0.71, 1.74) 1.28 (0.67, 2.45)
0.30–1.16 48 204 1.00 1.00
≥ 1.16 101 204 2.19 (1.46, 3.27) 2.04 (1.12, 3.72)
Abbreviation: OR odds ratio; CI confidential interval
a Unadjusted odds ratio
b Adjusted for gestational age, household income, pre-pregnancy body mass
index, parity, passive smoking, gestational hypertension
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tertile; adjusted OR = 2.74 (95 % CI = 1.07, 7.03) for the
highest tertile]. Although no significant interaction be-
tween maternal age and maternal urinary Mn levels was
observed (P heterogeneity = 0.19), a positive association
with LBW was only observed for the highest tertile
among older mothers (≥28 years) [adjusted OR = 1.98
(95 % CI = 0.82, 4.74)]. For mothers that gave birth to
female infants, lower and higher Mn levels were asso-
ciated with increased risk of LBW compared to the
medium tertile [adjusted OR = 2.12 (95 % CI: 0.86,
5.25) for the lowest tertile; adjusted OR = 1.94 (95 %
CI: 0.88, 4.45) for the highest tertile], although the as-
sociations were not significant. For mothers that gave
birth to male infants, a positive association with LBW
was only observed for the highest tertile of Mn [ad-
justed OR = 1.88 (95 % CI: 0.85, 4.79)]. Also, there
was no statistical evidence of heterogeneity in risk accord-
ing to infant sex (P heterogeneity = 0.24). Moreover, we
obtained consistent results with the restricted spline
models, showing that a non-linear risk pattern in younger
mothers and mothers who gave birth to female infants
(Additional file 1: Figure S1), though the non-linear rela-
tionship was only significant in mothers who gave birth to
female infants (P = 0.82 and P = 0.02, respectively). For
older mothers and mothers who gave birth to male in-
fants, we observed a possible linear trend between mater-
nal urinary Mn concentrations and risk of LBW (P = 0.03
and P = 0.08, respectively).
Discussion
In this nested case–control study, we observed an in-
creased risk of LBW for maternal urinary Mn levels in
the lowest tertile and highest tertile, though the associa-
tions with LBW risk were only significant for higher
levels of urinary Mn. These associations were observed
even after adjustment for known and suspected risk fac-
tors for LBW. We further identified a curvilinear rela-
tionship between maternal urinary Mn level and risk of
LBW, which was apparent in female infants. The ob-
served relationship was consistent with our a priori hy-
pothesis, and supports the idea that Mn may contribute
to adverse birth outcomes at both low and high expos-
ure levels.
The number of studies on biomarkers of Mn has been
increased during recent two decades, but the results on
the representative biomarkers of Mn are contradictory,
including Mn in urine, blood and hair. Some studies
showed that urinary Mn may have limited use for
occupational population as a direct measure of Mn
exposure due to high variability within person over time
[30, 31]. However, previous studies also have shown that
Mn detected in spot urine sample is able to correctly
classify individuals into the higher levels of Mn vs. the
lower levels of Mn exposure [20, 21]. Since behavior,
consumption habits, and ambient living environment of
individuals’ do not change easily, we used urinary Mn
concentration to divide the study populations into three
levels of exposure to investigate its association with risk
of LBW. Also, elevated urinary concentrations have been
reported to correlate to elevated concentrations of Mn in
drinking water in pregnant women living in Bangladeshi,
Fig. 1 The relationship between maternal urinary manganese
concentration (μg/g creatinine) and risk of LBW, adjusted for
gestational age, household income, pre-pregnancy body mass index,
parity, passive smoking, and gestational hypertension. The risk estimate
is indicated by the solid line, and the 95 % confidence intervals are
represented by the dashed lines
Table 3 Risk of low birth weight associated with maternal urinary manganese levels, stratified by maternal age
Manganese
levelsa
Age < 28 years old (n = 392) Age≥ 28 years old (n = 424) P for
heterogeneityCa/Co ORb (95 % CI) ORc (95 % CI) Ca/Co ORb (95 % CI) ORc (95 % CI)
Tertile 1 31/98 1.80 (0.91, 3.56) 1.88 (0.74, 4.80) 23/106 0.72 (0.39, 1.34) 0.84 (0.31, 2.24) 0.19
Tertile 2 17/98 1.00 1.00 31/106 1.00 1.00
Tertile 3 50/98 3.14 (1.67, 5.92) 2.74 (1.07, 7.03) 52/106 1.69 (0.98, 2.90) 1.98 (0.82, 4.74)
Abbreviations: ca/co, numbers of cases and controls; CI confidence interval; OR odds ratio
a Manganese levels (μg/g creatinine): age < 28 years, tertile 1 (<0.30), tertile 2 (0.30–1.08), tertile 3 (≥1.09); age ≥ 28 years, tertile 1 (<0.28), tertile 2 (0.28–1.21),
tertile 3(≥1.22)
b Crude odds ratio
c Adjusted for gestational age, household income, pre-pregnancy body mass index, parity, passive smoking, and gestational hypertension
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suggesting maternal urine may serve as a useful Mn bio-
marker to estimate prenatal exposure [22].
In the present study, none of our study participants
had a urinary Mn level higher than the upper limit of
normal urinary Mn values for adults (10 μg/L) [32].
Table 5 shows the comparison of Mn concentrations in
urine from this study and previous studies in pregnant
women and general population around the world. The
results showed that the Mn concentrations in maternal
urine observed in this study (median 0.38 μg/L, 0.69 μg/
g creatinine) were comparable to those seen in pregnant
women in western Australia (median 0.33 μg/L, 0.53 μg/
g creatinine) [33] and California, USA (0.40 μg/L) [34].
Compared to the pregnant women living in rural
Bangladesh with higher Mn concentrations in drinking
water than other places (median 1.60 μg/L) [22], our
study population had much lower urinary Mn concen-
trations. Previous studies have shown maternal blood
Mn levels were increased during pregnancy [10, 35, 36].
The increase in Mn levels during pregnancy may be
related to physiological factors, including increased
intestinal absorption or tissue Mn mobilization [37, 38],
reflecting increased need from the fetal development.
Takser et al. [10] reported that blood Mn concentration
in pregnant women at delivery was higher than non-
pregnant women of reproductive age. In consistent with
the findings, Mn concentrations in urine of pregnant
women in this study were a little higher than those ob-
served in the healthy women from Canada (median
0.09 μg/L) [39], Japan (median 0.16 μg/L, 0.13 μg/g cre-
atinine) [40], as well as the general population (including
men and women) in France (median 0.31 μg/L) [41] and
Germany (arithmetic mean 0.09 μg/L) [42].
Currently, there are no recommended values or guide-
lines for ideal urinary or blood Mn levels during preg-
nancy. In this study, we used the medium tertile of
urinary Mn as the reference group, and observed that
both the lowest and highest tertile were positively associ-
ated with LBW. One explanation for the weaker associ-
ation between the lowest tertile of Mn and LBW risk
might be that the prevalence of Mn deficiency is low in
our population. In a previous study, Eum et al. [15]
assessed the relationship between maternal blood Mn
levels before delivery and birth weight categorized as a
Table 4 Risk of low birth weight associated with maternal urinary manganese levels, stratified by infant sex
Manganese
levelsa
Male (n = 404) Female (n = 412) P for
heterogeneityCa/Co ORb (95 % CI) ORc (95 % CI) Ca/Co ORb (95 % CI) ORc (95 % CI)
Tertile 1 22/101 0.73 (0.38, 1.40) 0.64 (0.22, 1.83) 32/103 1.55 (0.81, 2.98) 2.12 (0.86, 5.25) 0.24
Tertile 2 29/101 1.00 1.00 20/103 1.00 1.00
Tertile 3 50/101 1.77 (1.02, 3.06) 1.88 (0.85, 4.79) 51/103 2.65 (1.46, 4.80) 1.94 (0.88, 4.45)
Abbreviations: ca/co, numbers of cases and controls; CI confidence interval; OR odds ratio
a Manganese levels (μg/g creatinine): male, tertile1 (<0.31), tertile 2 (0.31–1.24), tertile 3 (≥1.25); female, tertile 1 (<0.28), tertile 2 (0.28–1.04), tertile 3(≥1.05)
b Crude odds ratio
c Adjusted for gestational age, household income, pre-pregnancy body mass index, parity, passive smoking, and gestational hypertension
Table 5 Comparison of manganese concentrations in urine from the present study and previous studies
Percentiles







816 0.66 μg/L 1.12 μg/g
creatinine
0.13 μg/L 0.18 μg/g
creatinine
0.38 μg/L 0.69 μg/g
creatinine








173 1.00 μg/L 1.22 μg/g
creatinine












388 2.50 μg/L 0.90 μg/L 1.60 μg/L 2.80 μg/L
Canada Health Canada
(2010) [39]
Women 5309 0.15 μg/L < LOD 0.09 μg/L 0.17 μg/L
Japan Ohashi
(2006) [40]












87 0. 09 μg/L —— —— ——
—— No data
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binary variable (below 3000 g or more than 3000 g) in
331 full-term infants. They used the medium quintile as
the reference group and found that the lowest
(<16.9 μg/L) and the highest quintiles (≥26.9 μg/L) of
blood Mn were associated with an increased risk of
delivering infants with a birth weight below 3000 g.
However, the associations were not significant for the
lowest quintile (adjusted OR = 2.77; 95 % CI: 0.89,
8.65) and the highest quintile of Mn levels (adjusted
OR = 2.66; 95 % CI: 0.84, 8.08). Given that the risks
observed in that study were in relation to birth
weights < 3000 g, it is possible that they didn’t include
LBW infants or only included a small number of
LBW infants in the study.
Some previous studies also investigated the relationship
between maternal Mn exposure and infant birth weight.
Vigeh et al. [13] reported that intrauterine growth retard-
ation was positively associated with maternal blood Mn
and negatively associated with cord blood Mn in 271
mother-infant pairs from Tehran, Iran, but the study did
not evaluate non-linear relationships. Zota et al. [13]
found a non-linear relationship between maternal Mn
blood Mn levles and birth weight in a cohort of 470
mother–infant pairs from Oklahoma. They reported an
inverted U-shaped relationship between maternal blood
Mn levels and birth weight with a concentration of
31 μg/L as the point of inflection. The report of Eum
et al. [15] found a consistent result that the infant
birth weight increased with maternal blood Mn con-
centration up to 35 μg/L, and then decreased. Chen et al.
[14] also obtained similar results in a study of 172
mother-infant pairs in Shanghai in that an inverted U-
shaped relationship was found between maternal blood
Mn levels and birth weight. A similar parabolic dose–
response relationship between cord blood Mn concentra-
tions and birth weight was observed by Guan et al. [16] in
Dalian City, northern China (n = 125). Interestingly, in
consistent with the studies, we also found a potential
U-shaped relationship between maternal urinary Mn level
and risk of LBW. However, the non-linear relationship
may vary by maternal age and infant sex, and the non-
linear pattern was apparent in mothers who gave birth to
female infants.
Infant sex is known to influence pregnancy outcomes,
and female infants are usually at higher risk of LBW
since male infants have consistently higher birth weight
throughout gestation compared to female infants [43].
However, the relationship between maternal Mn levels
and infant sex has not been studied before. We observed
that the mothers who gave birth to male infants had
slightly higher Mn concentrations compared to mothers
who gave birth to female infants, which is one possible
explanation for why only higher but not lower Mn levels
were associated with LBW risk among male infants. In
addition, maternal age has been regarded as a factor that
can affect blood Mn levels [18, 44], and a previous study
also reported that urinary Mn levels increased at advanced
ages [40]. In our analyses stratified by maternal age, only
higher Mn exposure levels were associated with LBW risk
among older mothers, whereas for younger mothers both
lower and higher Mn levels were associated with an ele-
vated LBW risk. A reason for this difference might be that
the older mothers had elevated Mn concentrations com-
pared to younger mothers, though there was no significant
difference. The potential differences in the effect of Mn ex-
posure on LBW according to sex and maternal age ob-
served in this study should be interpreted carefully due to
the insufficient sample size, and further studies are needed
to confirm the results.
With respect to maternal exposure to higher levels of
Mn being associated with LBW, one biologically plausible
mechanism could be oxidative stress caused by high levels
of Mn, leading to impairment of cellular function and
growth [45]. Experimental studies on fetal development
also showed that maternal exposure to high levels of Mn
through oral administration resulted in a decrease in fetal
weight and retardation of the development of the skeleton
and internal organs [46]. There is also a concern that Mn
deficiency may cause adverse effects on fetal growth, in
that it is a critical component of the bone matrix and an
important cofactor for enzymes necessary for bone metab-
olism [47]. In animals, the main features of Mn deficiency
are skeletal malformation and impaired growth [48, 49].
Dietary deficiency of Mn has been associated with abnor-
mal glucose tolerance and perturbation of carbohydrate
metabolism in animal studies [50], which could also con-
tribute to fetal growth restriction. More research is needed
to assess the effect of Mn exposure during pregnancy on
subsequent child development.
One of the strengths of our study is that the nested
case–control design provided the opportunity to include
all of the LBW infants in the cohort, and the cases and
controls were matched on potentially important factors
in order to reduce the influence of confounding. The
other strength of our study includes the availability of
interview data and medical records from all participants,
which allowed us to adjust for other potential risk
factors for LBW.
The limitation of this study is that Mn levels were
measured in maternal urine at one spot time, which may
not accurately reflect maternal Mn load or fetal expos-
ure during the entire pregnancy. Biliary excretion is the
main pathway by which Mn is excreted with most of the
element ultimately being excreted in the feces [51], and
urinary Mn excretion representing about 5 % of the total
excreted amount [52]. Recent studies suggested that
levels of Mn measured in tooth dentin, toenails or cord
blood may constitute valid biomarkers of early life
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exposure [34, 53]. Future studies are needed that use
these biomarkers to investigate Mn exposure and birth
outcomes. In addition, repeated measures of erythro-
cytes Mn over trimesters may also provide an effective
biomarker for Mn exposure during pregnancy [36]. A
prospective study of Mn concentrations measured at dif-
ferent time points during pregnancy may help to evalu-
ate how Mn levels change over the course of the
pregnancy and whether there is a critical exposure win-
dow for the effect of Mn on fetal development.
Conclusions
Our nested case–control study found that both lower and
higher levels of Mn concentration, as measured in mater-
nal urine before delivery, was associated with increased
risk of infant LBW. The associations were further ob-
served to vary by maternal age and infant sex. This obser-
vation suggests that Mn levels during pregnancy may be
important for fetal growth.
Additional file
Additional file 1: Distribution of maternal urianry manganese and
restricted spline curves association between urinary manganese
concentration and risk of low birth weigh in the stratified analysis.
(DOCX 104 kb)
Abbreviations
LBW: Low birth weight; Mn: Manganese; CI: Confidence interval; OR: Odds
ratio; BMI: Body mass index; LOD: Limit of detection.
Competing interests
The authors have no conflict of interest to declare.
Authors’ contributions
WX and YZ wrote the manuscript. BZ, YL, AZ, YW, ZL, YY, TZ, and SX
contributed to the study design. BZ, TZ, and SX developed the initial
protocol. BB, JW, YW, and TZ reviewed and revised the manuscript. YZ, JH,
and XP performed the Mn analyses. WX, CX, and JZ performed the statistical
analyses. All authors reviewed and approved the manuscript.
Acknowledgments
This work was supported by the R&D Special Fund for Public Welfare
Industry (Environment) (201309048), the National Natural Science Foundation
of China (21437002, 81372959, 81402649), and the National Basic Research
Program of China (973 Program) (2012CB722401). Also, this work was partly
supported by Fogarty training grants (D43TW 008323 and D43TW 007864–01)
from the US National Institutes of Health.
Author details
1Key Laboratory of Environment and Health (HUST), Ministry of Education &
Ministry of Environmental Protection, and State Key Laboratory of
Environmental Health (Incubation), school of Public Health, Tongji Medical
College, Huazhong University of Science and Technology, Wuhan, Hubei,
People’s Republic of China. 2Department of Environmental Health Sciences,
Brown School of Public Health, Providence, RI, USA. 3Women and Children
Medical and Healthcare Center of Wuhan, Wuhan, Hubei, People’s Republic
of China. 4Department of Environmental Health Sciences, Yale School of
Public Health, New Haven, CT, USA. 5Wise Laboratory of Environmental and
Genetic Toxicology, Portland, ME, USA. 6Macheng Maternal and Child Health
Care Hospital, Macheng, Hubei, People’s Republic of China. 7Ezhou Maternal
and Child Health Hospital, Ezhou, Hubei, People’s Republic of China.
Received: 16 August 2015 Accepted: 3 February 2016
References
1. WHO. World Health Organization. Feto-maternal nutrition and low birth
weight. http://www.who.int/nutrition/topics/feto_maternal/en/ Accessed 24
Dec 2015. 2005
2. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where?
Why? Lancet. 2005;365(9462):891–900.
3. Johnson RC, Schoeni RF. Early-life origins of adult disease: national
longitudinal population-based study of the United States. Am J Public
Health. 2011;101(12):2317–24.
4. Crossgrove J, Zheng W. Manganese toxicity upon overexposure. NMR
Biomed. 2004;17(8):544–53.
5. He ZL, Yang XE, Stoffella PJ. Trace elements in agroecosystems and impacts
on the environment. J Trace Elem Med Bio. 2005;19(2–3):125–40.
6. Bouchard MF, Sauvé S, Barbeau B, Legrand M, Brodeur M-È, Bouffard T, et al.
Intellectual impairment in school-age children exposed to manganese from
drinking water. Envrion Health Perspect. 2011;119(1):138.
7. Menezes-Filho JA, Novaes CO, Moreira JC, Sarcinelli PN, Mergler D. Elevated
manganese and cognitive performance in school-aged children and their
mothers. Environ Res. 2011;111(1):156–63.
8. Hafeman D, Factor-Litvak P, Cheng Z, van Geen A, Ahsan H. Association
between manganese exposure through drinking water and infant mortality
in Bangladesh. Environ Health Perspect. 2007;115(7):1107–12.
9. Grazuleviciene R, Nadisauskiene R, Buinauskiene J, Grazulevicius T. Effects of
elevated levels of manganese and iron in drinking water on birth outcomes.
Pol J Envriron Stud. 2009;18(5):819–25.
10. Takser L, Lafond J, Bouchard M, St-Amour G, Mergler D. Manganese levels
during pregnancy and at birth: relation to environmental factors and
smoking in a Southwest Quebec population. Environ Res. 2004;95(2):119–25.
11. Mora AM, van Wendel de Joode B, Mergler D, Córdoba L, Cano C, Quesada
R, et al. Maternal blood and hair manganese concentrations, fetal growth,
and length of gestation in the ISA cohort in Costa Rica. Environl Res.
2015;136:47–56.
12. Vigeh M, Yokoyama K, Ramezanzadeh F, Dahaghin M, Fakhriazad E,
Seyedaghamiri Z, et al. Blood manganese concentrations and intrauterine
growth restriction. Reprod Toxicol. 2008;25(2):219–23.
13. Zota AR, Ettinger AS, Bouchard M, Amarasiriwardena CJ, Schwartz J, Hu H, et
al. Maternal blood manganese levels and infant birth weight. Epidemiology.
2009;20(3):367.
14. Chen L, Ding G, Gao Y, Wang P, Shi R, Huang H, et al. Manganese
concentrations in maternal–infant blood and birth weight. Environ Sci
Pollut R. 2014;21(9):6170–5.
15. Eum J-H, Cheong H-K, Ha E-H, Ha M, Kim Y, Hong Y-C, et al. Maternal blood
manganese level and birth weight: a MOCEH birth cohort study. Environ
Heal. 2014;13(1):31.
16. Guan H, Wang M, Li X, Piao F, Li Q, Xu L et al. Manganese concentrations in
maternal and umbilical cord blood: related to birth size and environmental
factors. Eur J Publlic health. 2013. DOI: http://dx.doi.org/10.1093/eurpub/ckt033.
17. Li M, Luo Y, Su Z. Heavy metal concentrations in soils and plant
accumulation in a restored manganese mineland in Guangxi. South China
Environ Pollut. 2007;147(1):168–75.
18. Audrey S, Takser L, André M, Martin S, Donna M, Geneviève S-A, et al.
A comparative study of manganese and lead levels in human umbilical
cords and maternal blood from two urban centers exposed to different
gasoline additives. Sci Total Environ. 2002;290(1):157–64.
19. Krachler M, Rossipal E, Micetic-Turk D. Trace element transfer from the
mother to the newborn - Investigations on triplets of colostrum, maternal
and umbilical cord sera. Eur J Clin Nutr. 1999;53:486–94.
20. Hassani H, Golbabaei F, Shirkhanloo H, Doust MT. Relations of biomarkers of
manganese exposure and neuropsychological effects among welders and
ferroalloy smelters. Ind Health. 2015. doi: http://doi.org/10.2486/indhealth.
2014-0250.
21. Järvisalo J, Olkinuoral M, Kiilunen M, Kivistö H, Ristola P, Tossavainen A, et al.
Urinary and blood manganese in occupationally nonexposed populations
and in manual metal are welders of mild steel. Int Arch Occup Environ
Health. 1992;63(7):495–501.
22. Ljung KS, Kippler MJ, Goessler W, Grandér GM, Nermell BM, Vahter ME.
Maternal and early life exposure to manganese in rural Bangladesh. Environ
Sci Technol. 2009;43(7):2595–601.
Xia et al. BMC Public Health  (2016) 16:142 Page 8 of 9
23. Liu B, Feng W, Wang J, Li Y, Han X, Hu H, et al. Association of urinary metals
levels with type 2 diabetes risk in coke oven workers. Environ Pollut.
2016;210:1–8.
24. Lucchini RG, Guazzetti S, Zoni S, Benedetti C, Fedrighi C, Peli M, et al.
Neurofunctional dopaminergic impairment in elderly after lifetime exposure
to manganese. Neurotoxicology. 2014;45:309–17.
25. Andrews KW, Savitz DA, Hertz‐Picciotto I. Prenatal lead exposure in relation
to gestational age and birth weight: a review of epidemiologic studies. Am
J Ind Med. 1994;26(1):13–32.
26. Hopenhayn C, Ferreccio C, Browning SR, Huang B, Peralta C, Gibb H, et al.
Arsenic exposure from drinking water and birth weight. Epidemiology.
2003;14(5):593–602.
27. Hu X, Zheng T, Cheng Y, Holfordb T, Linc S, Leaderer B, et al. Distributions
of heavy metals in the maternal and cord blood and the association with
infant birth weight in China. J Reprod Med. 2015;60(1–2):21–9.
28. Kippler M, Tofail F, Gardner R, Rahman A, Hamadani JD, Bottai M, et al.
Maternal cadmium exposure during pregnancy and size at birth: a
prospective cohort study. Environ Health Perspect. 2012;120(2):284–9.
29. Li RHE, Louie M, Chen L, Spiegelman D. The SAS LGTPHCURV8 Macro.
Boston: Channing Laboratory; 2006.
30. Smith D, Gwiazda R, Bowler R, Roels H, Park R, Taicher C, et al. Biomarkers of
Mn exposure in humans. Am J Ind Med. 2007;50(11):801–11.
31. Baker MG, Simpson CD, Sheppard L, Stover B, Morton J, Cocker J, et al.
Variance components of short-term biomarkers of manganese exposure in an
inception cohort of welding trainees. J Trace Elem Med Bio. 2015;29:123–9.
32. McClatchey KD. Clinical laboratory medicine. 2nd ed. Philadelphia :
Lippincott Williams & Wilkins; 2002. p. 425.
33. Callan A, Hinwood A, Ramalingam M, Boyce M, Heyworth J, McCafferty P, et
al. Maternal exposure to metals—concentrations and predictors of
exposure. Environ Res. 2013;126:111–7.
34. Gunier R, Mora AM, Smith DR, Arora M, Austin C, Eskenazi B, et al.
Biomarkers of manganese exposure in pregnant women and children living
in an agricultural community in California. Environ Sci Technol.
2014;48(24):14695–702.
35. Tholin K, Palm R, Hallmans G, Sandström B. Manganese status during
pregnancy. Ann Ny Acad Sci. 1993;678(1):359–60.
36. Tsai M-S, Liao K-W, Chang C-H, Chien L-C, Mao IF, Tsai Y-A, et al. The critical
fetal stage for maternal manganese exposure. Environ Res. 2015;137:215–21.
37. Kirchgessner M, Sherif Y, Schwarz F. Changes in absorption of manganese
during gravidity and lactation. Ann Nutr Metab. 1981;26(2):83–9.
38. Das K, Chowdhury A. Metallic ion concentration during menstrual cycle in
normally menstruating women. Ind J Med Sci. 1997;51(2):52.
39. Health Canada. Report on Human Biomonitoring of Environmental
Chemicals in Canada: Results of the Canadian Health Measures Survey Cycle
1 (2007–2009). http://www.hc-sc.gc.ca/ewh-semt/alt_formats/hecs-sesc/pdf/
pubs/contaminants/chms-ecms/report-rapport-eng.pdf. Accessed 24 Dec
2015. 2010
40. Ohashi F, Fukui Y, Takada S, Moriguchi J, Ezaki T, Ikeda M. Reference values
for cobalt, copper, manganese, and nickel in urine among women of the
general population in Japan. Int Arch Occ Env Hea. 2006;80(2):117–26.
41. Goullé J-P, Mahieu L, Castermant J, Neveu N, Bonneau L, Lainé G, et al.
Metal and metalloid multi-elementary ICP-MS validation in whole blood,
plasma, urine and hair: Reference values. Forensic Sci Int. 2005;153(1):39–44.
42. Heitland P, Köster HD. Biomonitoring of 30 trace elements in urine of
children and adults by ICP-MS. Clin Chim Acta. 2006;365(1–2):310–8.
43. Ghosh R, Rankin J, Pless-Mulloli T, Glinianaia S. Does the effect of air
pollution on pregnancy outcomes differ by gender? A systematic review.
Enviro Res. 2007;105(3):400-408.
44. Lin Y-Y, Leon Guo Y-L, Chen P-C, Liu J-H, Wu H-C, Hwang Y-H. Associations
between petrol-station density and manganese and lead in the cord blood
of newborns living in Taiwan. Environl Res. 2011;111(2):260–5.
45. Erikson KM, Dorman DC, Fitsanakis V, Lash LH, Aschner M. Alterations of
oxidative stress biomarkers due to in utero and neonatal exposures of
airborne manganese. Biol Trace Elem Res. 2006;111(1–3):199–215.
46. Sánchez DJ, Domingo J, Llobet JM, Keen CL. Maternal and developmental
toxicity of manganese in the mouse. Toxicol Lett. 1993;69(1):45–52.
47. Palacios C. The role of nutrients in bone health, from A to Z. Crit Rev Food
Sci. 2006;46(8):621–8.
48. Aschner JL, Aschner M. Nutritional aspects of manganese homeostasis. Mol
Aspects Med. 2005;26(4):353–62.
49. Hansen S, Spears J, Lloyd K, Whisnant C. Feeding a low manganese diet to
heifers during gestation impairs fetal growth and development. J Dairy Sci.
2006;89(11):4305–11.
50. Keen C, Ensunsa J, Watson M, Baly D, Donovan S, Monaco M, et al.
Nutritional aspects of manganese from experimental studies.
Neurotoxicology. 1999;20(2–3):213–23.
51. Erikson KM. Manganese Dosimetry: Species Differences and Implications for
Neurotoxicity. 2005
52. Smargiassi A, Mutti A. Peripheral biomarkers and exposure to manganese.
Neurotoxicology. 1998;20(2–3):401–6.
53. Rodrigues EG, Kile M, Dobson C, Amarasiriwardena C, Quamruzzaman Q,
Rahman M, et al. Maternal–infant biomarkers of prenatal exposure to
arsenic and manganese. J Expo Sci Env Epid. 2015;25(6):639–48.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Xia et al. BMC Public Health  (2016) 16:142 Page 9 of 9
